Research Alliance Corp. II

Status: Liquidated
U=S
IPO Proceeds, $M $149.50M
IPO Date Mar 18, 2021
CEO Peter Kolchinsky, Ph.D.
Left Lead Jefferies
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Biotechnology

IPO Geography Global
Target Company N/A
Deal Announced N/A
Deal Size, $M TBD
Deal Sector TBD
Deal Geography TBD
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote Dec 2, 2022
Closing Date Dec 2, 2022
RACB

Sign up for Free Trial

No credit card required

Sign in for more on Research Alliance Corp. II:

  • Structure and cap table
  • 6 directors & officers
  • 12 filings and events
  • 1 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Peter Kolchinsky, Ph.D. 44 CEO & Chairman
Tess Cameron 35 CFO
Matthew Hammond, Ph.D. 32 CIO & Director
Stephen J. Hoffman, M.D., Ph.D. 67 Director
Thomas Leggett 44 Director
Clive Patience 57 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Jefferies BR 13,000,000 units
13,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Filings

Sign in to view 12 filings.

Shareholders

Sign in to view shareholders 13F filing data.